For example, ALK inhibitors such as crizotinib or ceritinib are used for different neoplasms with an over-activated ALK kinase (usually caused by an EML4-ALK rearrangement) such as neuroblastoma, non-small-cell lung carcinoma or anaplastic large cell lymphoma [42]. The gene discussed is ALK; the disease is neoplasm.